×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| IPCA LABORATORIES LTD. | 16,800.90 | 2,675.60 | 16,626.80 | 10.55 | 36,659 | 49.9 |
| Global Health Limited | 9594.6 | 1428.58 | 9434.36 | 5.32 | 33185 | 65.4 |
| AJANTA PHARMA LTD. | 11,765.70 | 2,328.80 | 11,461.30 | 18.59 | 32558 | 36.3 |
Ipca Laboratories Ltd., with Security Code 524494, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,484.8 | 1,432.7 | 1,401.6 | 1,488.7 | 1,662.6 | 1,506.8 | 1,510.6 | 1,565.8 | 1,810.9 | 1,662.6 |
| Expenses | 1,212.9 | 1,218.8 | 1,226.0 | 1,191.2 | 1,353.7 | 1,233.3 | 1,218.3 | 1,212.6 | 1,408.8 | 1,251.6 |
| Operating Profit | 271.9 | 214.0 | 175.6 | 297.5 | 309.0 | 273.5 | 292.3 | 353.2 | 402.1 | 411.1 |
| OPM % | 18.31% | 14.94% | 12.53% | 19.99% | 18.58% | 18.15% | 19.35% | 22.56% | 22.2% | 24.72% |
| Other Income | 36.6 | 25.3 | 33.5 | 43.2 | 36.1 | 16.9 | -79.2 | 15.4 | 17.0 | 17.4 |
| Interest | 9.0 | 10.4 | 17.7 | 30.8 | 38.6 | 27.2 | 24.1 | 19.4 | 17.3 | 10.2 |
| Depreciation | 54.9 | 57.0 | 59.2 | 60.4 | 61.4 | 63.0 | 61.8 | 61.3 | 62.7 | 62.8 |
| Profit before tax | 244.6 | 171.8 | 132.2 | 249.6 | 245.1 | 200.2 | 221.6 | 287.9 | 339.2 | 355.5 |
| Tax % | 31.4% | 30% | 35.8% | 33.3% | 33.9% | 31.6% | 49.1% | 29.1% | 28% | 24.7% |
| Net Profit | 167.8 | 120.3 | 84.8 | 166.6 | 162.1 | 136.9 | 64.8 | 204.1 | 244.1 | 267.6 |
| EPS in Rs | 6.61 | 4.74 | 3.34 | 6.57 | 6.39 | 5.4 | 2.55 | 8.05 | 9.62 | 10.55 |
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,585.7 | 1,601.0 | 1,546.0 | 1,511.6 | 1,587.6 | 2,034.0 | 2,052.9 | 2,033.0 | 2,092.6 | 2,354.9 |
| Expenses | 1,319.7 | 1,341.2 | 1,336.0 | 1,333.5 | 1,282.1 | 1,713.6 | 1,723.2 | 1,712.7 | 1,699.9 | 1,913.4 |
| Operating Profit | 266.0 | 259.7 | 210.0 | 178.1 | 305.5 | 320.3 | 329.7 | 320.3 | 392.7 | 441.5 |
| OPM % | 16.8% | 16.2% | 13.6% | 11.8% | 19.2% | 15.7% | 16.1% | 15.8% | 18.8% | 18.7% |
| Other Income | 22.1 | 36.2 | 30.9 | 36.4 | 44.9 | 38.6 | 90.5 | -117.8 | 20.6 | 26.3 |
| Interest | 6.9 | 9.3 | 10.8 | 18.5 | 31.4 | 44.1 | 33.4 | 29.4 | 24.1 | 22.6 |
| Depreciation | 61.7 | 63.7 | 66.6 | 69.5 | 69.3 | 90.3 | 99.5 | 98.1 | 98.9 | 100.4 |
| Profit before tax | 219.5 | 222.9 | 163.5 | 126.5 | 249.7 | 224.4 | 219.2 | 211.7 | 290.4 | 344.8 |
| Tax % | 33.3% | 34.4% | 31.7% | 37.4% | 34% | 39% | 22.9% | 96.2% | 31.5% | 28.8% |
| Net Profit | 145.2 | 145.9 | 109.7 | 78.1 | 164.1 | 136.5 | 221.0 | 1.3 | 199.1 | 245.8 |
| EPS in Rs | 5 | 5 | 4 | 3 | 6 | 5 | 7 | 2 | 7 | 9 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 11% |
| 3 Years: | 6% |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 6% |
| 3 Years: | -19% |
| TTM: | 44% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 15% |
| 3 Years: | 15% |
| 1 Year: | 19% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 15% |
| 3 Years: | 12% |
| TTM: | 21% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 5% |
| 3 Years: | -21% |
| TTM: | 37% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 15% |
| 3 Years: | 15% |
| 1 Year: | 19% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|